Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [820]

ASCO 2016: Current treatment approaches for advanced prostate cancer

Prof Przemyslaw Twardowski and Prof Gordon McVie

ASCO 2016: Current treatment approaches for advanced prostate cancer ( Prof Przemyslaw Twardowski and Prof Gordon McVie )

Neuroblastoma outcomes improved with second stem cell transplant

Dr Julie Park - Seattle Children's Hospital, Seattle, USA

Neuroblastoma outcomes improved with second stem cell transplant ( Dr Julie Park - Seattle Children's Hospital, Seattle, USA )

Adjuvant docetaxel fails after radical prostatectomy for high risk prostate...

Dr Goran Ahlgren - Lund University, Malmö, Sweden

Adjuvant docetaxel fails after radical prostatectomy for high risk prostate cancer ( Dr Goran Ahlgren - Lund University, Malmö, Sweden )

Upfront autologous stem cell transplantation for newly diagnosed multiple...

Prof Michele Cavo - Seràgnoli Institute of Hematology, Bologna, Italy

Upfront autologous stem cell transplantation for newly diagnosed multiple myeloma ( Prof Michele Cavo - Seràgnoli Institute of Hematology, Bologna, Italy )

Surgery in stage 4 breast cancer increased survival

Prof Atilla Soran - University of Pittsburgh, Pennsylvania, USA

Surgery in stage 4 breast cancer increased survival ( Prof Atilla Soran - University of Pittsburgh, Pennsylvania, USA )

ASCO 2016: Advances in Prostate Cancer

Prof Karim Fizazi, Prof Maria De Santis, Prof Bertrand Tombal and Dr Mark...

ASCO 2016: Advances in Prostate Cancer ( Prof Karim Fizazi, Prof Maria De Santis, Prof Bertrand Tombal and Dr Mark Beresford )

Phase II study of intraperitoneal versus intravenous chemotherapy following...

Dr Helen Mackay - Sunnybrook Research Institute, Toronto, Canada

Phase II study of intraperitoneal versus intravenous chemotherapy following neoadjuvant chemotherapy and optimal debulking surgery in epithelial ovarian cancer ( Dr Helen Mackay - Sunnybrook Research Institute, Toronto, Canada )

New technology can potentially overcome CAR T-cell limitations

Dr Philip Low - Purdue University, West Lafayette, USA

New technology can potentially overcome CAR T-cell limitations ( Dr Philip Low - Purdue University, West Lafayette, USA )

WIN 2016: Preview of Speakers

Dr John Mendelsohn - Chairman of the WIN Consortium

WIN 2016: Preview of Speakers ( Dr John Mendelsohn - Chairman of the WIN Consortium )

Complementary drug delivery techniques for interstitial administration

Dr Ruman Rahman - University of Nottingham, Nottingham, UK

Complementary drug delivery techniques for interstitial administration ( Dr Ruman Rahman - University of Nottingham, Nottingham, UK )

Editor's choice for January 2016

Prof Gordon McVie - ecancer Editor

Editor's choice for January 2016 ( Prof Gordon McVie - ecancer Editor )

Comparing adjuvant radiotherapy plus chemo vs. adjuvant chemo following...

Dr Brian Baumann - University of Pennsylvania, Philadelphia, USA

Comparing adjuvant radiotherapy plus chemo vs. adjuvant chemo following cystectomy for bladder cancer ( Dr Brian Baumann - University of Pennsylvania, Philadelphia, USA )

More from ecancer